Some installations of the Guangkang Biochemical (300804.SZ) subsidiary construction project have entered the trial production stage

Zhitongcaijing · 1d ago

According to Zhitong Finance App, Guangkang Biochemical (300804.SZ) issued an announcement. On September 29, 2026, Hubei Shengkang Chemical Co., Ltd. (“Shengkang Chemical”), a wholly-owned subsidiary of the company, received the “Notice of Trial Production of Hazardous Chemical Construction Projects” [Yigao Hazard Project Notice (2026) No. 14] issued by the Emergency Management Bureau of the Yichang High-tech Zone Management Committee. The Emergency Management Bureau of the Yichang High-tech Zone Management Committee agreed to the trial production plan for Shengkang Chemical's 2-nitro-3-methylbenzoic acid production plant and the company's fund-raising investment project “Special Chemical Construction Project with an annual output of 5,500 tons”. The trial production period is from October 9, 2026 to October 8, 2027. Subsequently, Shengkang Chemical will strictly follow the requirements of laws and regulations and product production processes, arrange trial production work in an orderly manner, and gradually push the trial production equipment to meet production standards.

2-nitro-3-methylbenzoic acid is an important organic synthesis intermediate. The core use is to synthesize N,3-dimethyl-5-chloro-2-aminobenzamide (K-amine), and ultimately used to produce the high-efficiency insecticide chloramphenicamide. The gradual release of 2-nitro-3-methylbenzoic acid production capacity will help the company expand its production scale, enrich its product structure, expand its customer base, and have a positive impact on the company's future business performance.